The statistical risk of diagnosing coincidental acquired hemophilia A following anti‐SARS‐CoV‐2 vaccination
We read with interest the case report by Radwi et al. of a 69 year-old man with acquired hemophilia A (AHA) following vaccination with the Pfizer-BioNTech SARS CoV-2 mRNA vaccine (1). The publication prompted us to perform a survey within the Working Party Haemostasis of the Swiss Society of Hematol...
Saved in:
Published in | Journal of Thrombosis and Haemostasis Vol. 19; no. 9; pp. 2360 - 2362 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article Web Resource |
Language | English |
Published |
England
John Wiley & Sons, Inc
01.09.2021
Elsevier Limited International Society on Thrombosis and Haemostasis. Published by Elsevier Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We read with interest the case report by Radwi et al. of a 69 year-old man with acquired hemophilia A (AHA) following vaccination with the Pfizer-BioNTech SARS CoV-2 mRNA vaccine (1). The publication prompted us to perform a survey within the Working Party Haemostasis of the Swiss Society of Hematology to detect similar cases in Switzerland. The survey led to the identification of three cases of AHA in Switzerland between December 23rd 2020 and April 30th 2021. |
---|---|
Bibliography: | Final decision: David Lillicrap, 29 May 2021 Cittone and Battegay contributed equally to this article. Gerber On behalf of the Working Party Haemostasis Switzerland Manuscript handled by: David Lillicrap |
ISSN: | 1538-7933 1538-7836 1538-7836 |
DOI: | 10.1111/jth.15421 |